ECCEO11-IOF » ESCEO-FROMO Symposia

Wednesday, 23 March
17:00 18:30	ESCEO-FROMO Symposium Rheumatic diseases and bone (Chairman: C. Cooper) Bone and arthritides: New developments in the osteo-immunology arena - J.-P. David Therapeutic targets for bone changes in inflammatory arthritis - J. Louie Systemic lupus erythematosus, cytokines and bone - A. Chines New perspectives in the registration of drugs for rheumatoid arthritis - B. Avouac Biomarkers in the diagnosis, monitoring and prognosis of rheumatoid arthritis - P. Miossec	ESCEO Room 1 - 1st floor
Thursday, 24 March
14:00 15:00	ESCEO-FROMO Symposium Long-term treatment of osteoporosis (Chairmen: R. Rizzoli and C. Cooper) Welcome - J.-Y. Reginster Long-term treatment with calcium and vitamin D - R. Rizzoli Long-term treatment with selective estrogen receptor modulators - M. Diaz Curiel Long-term treatment with bisphosphonates - R. Lorenc Long-term treatment with strontium ranelate - B. Cortet Discussion - S. Epstein, J.-Y. Reginster	ESCEO room 2 - 1st Floor
14:00 15:00	ESCEO-FROMO Symposium How should partial adherence be taken into account in health economic models in osteoporosis? (Chairmen: J.A. Kanis - M. Hiligsmann) Welcome and introduction - J-Y. Reginster Basing adherence on empirical observations and how does partial adherence impact on anti-fracture efficacy - M. Hiligsmann and V. Rabenda Impact of adherence on health economic assessment in post-menopausal osteoporosis - J. Kanis Discussion - J.A. Kanis, S. Corcaud, V. Rabenda, E. Badamgarav, M. Hiligsmann, S. Korte, W. Dere, B. Mitlak, P. Alegre, J-Y. Reginster	ESCEO room 1 - 1st Floor
Friday, 25 March
14:00 15:00	ESCEO-FROMO Symposium Recommendations for the design of clinical trials to be conducted by food and food supplements, in order to be granted the right to use health claims in osteoporosis (in collaboration with GREES) (Chairmen: R. Rizzoli and O. Bruyère) Welcome - J.-Y. Reginster Why do we need guidelines before granting health claims authorization to food supplement? - V. Coxam Regulatory approach of health claims for food supplements in Europe - A. Martin Health claims in osteoporosis for food supplements - O. Bruyère Discussion - B. Avouac	ESCEO Room 1 - 1st floor
14:00 15:00	ESCEO-FROMO Symposium Generic versus branded medication in osteoporosis: Are they really similar ? (Chairmen: J. D. Adachi – J. A. Kanis) Welcome and introduction - J. A. Kanis Generic medications: definition and regulatory aspects in Europe - J.-M. Kaufman Brand versus generic bisphosphonates: are they equally effective and tolerated - J. Ringe Brand versus generic bisphosphonates: implications for patient management - J. D. Adachi Discussion - C. Cooper, J.-M. Kaufman, J. Ringe, J. D. Adachi, M. Hiligsmann, J. A. Kanis, J.-Y. Reginster. Conclusion - J. A. Kanis.	ESCEO Room 2 - 1st Floor
17:00 18:30	ESCEO-FROMO Symposium Frailty and Sarcopenia: State of the art (Chairmen: R. Rizzoli – J.A. Kanis) Welcome and introduction - J.-Y. Reginster Definition of frailty syndrome - C. Cooper Epidemiology of frailty syndrome - A.A. Sayer Pathophysiology of physical frailty: Inflammatory mechanisms - C. Sieber Pathophysiology of physical frailty: Hormonal mechanisms - J.-M. Kaufman Methodology of evaluation of Sarcopenia and Frailty - G. Abbelan van Kan Future pathway for registering therapeutics in Sarcopenia and Frailty - W.J. Evans Discussion - J. A. Kanis, R. Rizzoli, J.-M. Kaufman, C. Cooper, A.A. Sayer, C. Sieber, G. Abbelan van Kan, W. J. Evans, R. Adachi, S. Boonen, W. Dere, B. Mitlak, Y. Tsouderos, J.-Y. Reginster.	ESCEO Room 2 - 1st floor
Saturday, 26 March
12:15 13:45	ESCEO-FROMO Symposium Bone repair with anti-osteoporosis medications (Chairmen: J. Goldhahn – J.A. Kanis) Welcome and introduction - J.-Y. Reginster Bone repair: Facts and challenges - J. Goldhahn. Preclinical evaluation of bone repair - J. Goldhahn Osteoporosis treatment and fracture healing - Clinical evidence - S. Boonen Discussion - J. Goldhahn, S. Boonen, B. Mitlak, J.M. Feron, W. Dere, S. Papapoulos, Y. Tsouderos, J.A. Kanis, J.-Y. Reginster.	ESCEO Room 2 - 1st floor
14:00 15:30	ESCEO-FROMO Symposium Adverse reactions and drug-drug interactions in the management of osteoporosis (Chairmen: R. Rizzoli - A. Diez-Perez) Welcome - J.-Y. Reginster Bisphosphonates: Adverse Reactions and Drug-Drug Interactions - C Cooper SERMs: Adverse Reactions and Drug-Drug Interactions - J.-M. Kaufman Strontium Ranelate: Adverse Reactions and Drug-Drug Interactions - J. Ringe Teriparatide: Adverse Reactions and Drug-Drug Interactions - A. Diez-Perez Denosumab: Adverse Reactions and Drug-Drug Interactions - D. Felsenberg Discussion Leader - A. Diez-Perez Summary of the ESCEO working group guidance - C. Cooper.	ESCEO Room 1 - 1st floor

Events plugin by anmari